BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 30360849)

  • 1. Medical and lifestyle management of peripheral arterial disease.
    Parvar SL; Fitridge R; Dawson J; Nicholls SJ
    J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive medical management of peripheral arterial disease.
    Gandhi S; Weinberg I; Margey R; Jaff MR
    Prog Cardiovasc Dis; 2011; 54(1):2-13. PubMed ID: 21722781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of Canadian Vascular Surgeons Toward Pharmacologic Risk Reduction in Patients with Peripheral Artery Disease: 2018 Update.
    Li B; Salata K; de Mestral C; Hussain MA; Aljabri BA; Lindsay TF; Verma S; Al-Omran M
    Ann Vasc Surg; 2019 Jul; 58():166-173.e4. PubMed ID: 30771465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotics in stable peripheral artery disease.
    Kaplovitch E; Rannelli L; Anand SS
    Vasc Med; 2019 Apr; 24(2):132-140. PubMed ID: 30799766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical treatment of peripheral arterial disease.
    Hankey GJ; Norman PE; Eikelboom JW
    JAMA; 2006 Feb; 295(5):547-53. PubMed ID: 16449620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of aspirin and clopidogrel resistance in peripheral arterial disease.
    Guirgis M; Thompson P; Jansen S
    J Vasc Surg; 2017 Nov; 66(5):1576-1586. PubMed ID: 28893489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.
    Kobayashi T; Parikh SA; Giri J
    Curr Cardiol Rep; 2015 Oct; 17(10):86. PubMed ID: 26280273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy for peripheral arterial disease.
    Simmons A; Steffen K; Sanders S
    Curr Opin Cardiol; 2012 Nov; 27(6):592-7. PubMed ID: 23032711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Invasive Therapy of Peripheral Arterial Disease.
    Marcial JM; Pérez R; Vargas P; Franqui-Rivera H
    Bol Asoc Med P R; 2015; 107(3):52-7. PubMed ID: 26742197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of the effects of supervised exercise therapy on modifiable cardiovascular risk factors in intermittent claudication.
    Jansen SCP; Hoorweg BBN; Hoeks SE; van den Houten MML; Scheltinga MRM; Teijink JAW; Rouwet EV
    J Vasc Surg; 2019 Apr; 69(4):1293-1308.e2. PubMed ID: 30777692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary and optimal medical management of peripheral arterial disease.
    Tattersall MC; Johnson HM; Mason PJ
    Surg Clin North Am; 2013 Aug; 93(4):761-78, vii. PubMed ID: 23885930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do we have a unified consensus on antithrombotic management of PAD?
    Poredos P; Antignani PL; Blinc A; Fras Z; Jezovnik MK; Fareed J; Mansilha A
    Int Angiol; 2021 Jun; 40(3):229-239. PubMed ID: 33739074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study).
    Cimminiello C; Arpaia G; Polo Friz H; Boracchi P; Marano G; Spezzigu G; Visonà A
    Vasa; 2015 Sep; 44(5):371-9. PubMed ID: 26317257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical considerations after endovascular therapy of peripheral artery disease.
    Giannopoulos S; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2021 May; 19(5):369-378. PubMed ID: 33870848
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical risk factor treatment in peripheral arterial disease. Need for further improvement.
    Alhadad A; Wictorsson C; Alhadad H; Lindblad B; Gottsäter A
    Int Angiol; 2013 Jun; 32(3):332-8. PubMed ID: 23711686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.